A GLP-1 program is not a single appointment. It is a chain of responsibilities: someone evaluates your health, someone prescribes a specific product, a pharmacy dispenses it, and a clinical team handles questions afterward. Allure Medical describes the beginning and continuing-care portions of that chain more clearly than the medication handoff in between. Its published program includes prescription GLP-1 injections, eligibility screening, clinical monitoring and lifestyle guidance. The practical question is how those promises translate into a complete, usable treatment pathway.
This documentary review examines Allure Medical’s public pages consulted October 19, 2026, primarily material associated with Raleigh and the organization’s broader website. The practice advertises locations in Michigan, North Carolina and South Carolina, alongside general telehealth access. However, the reviewed documentation does not establish which GLP-1 products it prescribes, which pharmacies dispense them or what treatment costs. Those are important gaps to resolve before enrolling—not evidence that the program lacks those arrangements.
At a glance
- Documented program
- Allure Medical advertises medically guided GLP-1 injections with prescription medication, clinical monitoring, lifestyle guidance and ongoing medical-team support.Sources: [7]
- Initial evaluation
- The published screening considers medical history, goals, BMI, current medicines and risk factors; a prescription is not presented as automatic.Sources: [7]
- Geographic footprint
- The GLP-1 page advertises locations across Michigan, North Carolina and South Carolina, without defining statewide prescribing or telehealth availability.
- Price distinction
- The advertised membership starting at $179 per month is an aesthetic offer, not a documented GLP-1 treatment price.Sources: [3]
- Medication handoff
- The consulted GLP-1 documentation does not name specific medicines or dispensing pharmacies, or explain shipping, pickup and refrigeration arrangements.Sources: [7]
Start by establishing which Allure service you are booking
Allure Medical is a broader medical and cosmetic practice, not a website devoted exclusively to weight-management prescriptions. Its privacy policy identifies the business as Allure Medical Spa PLLC, operating as Allure Medical. The organization describes itself as physician-led, combining hormone health, wellness and cosmetic treatment. Its website identifies founder Charles Mok, D.O., and says he received his medical degree in 1989. These are provider-published identity and credential statements, not independently verified licensing findings.
Weight management is itself a multi-service category at Allure. Alongside its GLP-1 offering, the catalog lists Apollo ESG and the Orbera gastric balloon. That matters when using a general inquiry form or discussing a consultation: a weight-loss appointment does not, by itself, identify the medication program or its terms. Ask specifically for the GLP-1 service and confirm which location and clinical team will handle the evaluation, prescription and follow-up.
The GLP-1 page also states that Allure is LegitScript certified. That is a commercial credential claim made by the practice; this review did not independently verify it. Neither the physician-led description nor that certification statement answers the operational questions that remain about dispensing, access and follow-up. Our guide to the GLP-1 care journey provides a useful framework for separating those responsibilities rather than treating the practice name as the entire care pathway.
| Stage | What Allure documents | What to confirm directly |
|---|---|---|
| Consultation | Health history, weight history, goals and contraindication review | GLP-1 consultation fee, format and treating clinician |
| Treatment selection | Individualized recommendation for eligible patients | Exact product, formulation and prescribing indication |
| Dispensing | Prescription medication is described as part of the program | Dispensing pharmacy, pickup or shipping, and charges |
| Follow-up | Monitoring, support and clinically appropriate plan adjustments | Visit schedule, response times and after-hours arrangements |
| Payment | General personalized treatment plans discuss pricing | Itemized GLP-1 charges, billing intervals and cancellation terms |
The consultation has a defined purpose, but access needs confirmation
Allure says GLP-1 treatment should follow a consultation, health review and individualized recommendation from a qualified healthcare provider. Its initial consultation description includes goals, weight history, medical history and potential contraindications. Eligibility screening also considers BMI, current medications and risk factors. This is a documented assessment process rather than a promise that submitting an inquiry or attending an appointment will result in a prescription.
The program is described for adults, often those with obesity or overweight plus at least one weight-related condition. Allure lists BMI guideposts of 30 or higher, or 27 or higher with a weight-related condition. These are the practice’s published screening parameters, not a determination that any particular reader qualifies. Allure also says treatment may not be appropriate for patients who are pregnant, breastfeeding or planning pregnancy, or who have certain personal or family medical histories, including medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). The clinician must assess suitability for the specific medication proposed. Its pages do not provide a separate numerical minimum age for the GLP-1 program or enough information to resolve individual eligibility.
Access claims require similar precision. Allure’s general website advertises same-day appointments and virtual telehealth visits, while its GLP-1 page points to locations in three states. The documentation does not confirm that every GLP-1 consultation can happen virtually, that same-day prescribing is available or that residents throughout those states can receive treatment. Before booking, verify your location, the appointment format and whether any later visits must occur in person.
Prepare for a health discussion, not just a weight check
Allure gives prospective patients concrete preparation instructions. It asks for a list of current medications and supplements and disclosure of histories including diabetes, thyroid disease, pancreatitis, gallbladder disease, gastrointestinal issues and kidney disease. It also asks about previous weight-loss programs, medications and surgeries. Bringing those details makes the appointment more useful than arriving with a target weight alone, especially when the clinician must understand what has already been tried.
The practice also asks patients to discuss nutrition, activity, sleep, stress and daily habits. If someone is a candidate, Allure says the provider recommends a plan based on their needs, explains how treatment works and discusses what to watch for. Its lifestyle-support description includes nutrition, adequate protein and hydration, resistance training and regular movement. These are descriptions of the program’s intended support, not evidence of a specified number of coaching sessions or access to a dietitian.
The public material does not establish mandatory laboratory testing, whether outside results are accepted or whether testing carries a separate charge. Those are useful questions to raise before the appointment, particularly if another clinician already has relevant records. The first-consultation preparation guide can help organize a concise history and question list. Ask Allure which documents it wants and how to transmit medical records through an appropriate channel.
The prescription and pharmacy handoff remain the largest gaps
Allure explicitly advertises prescription GLP-1 injections, but the consulted program page does not name the active ingredients, brands, presentations or dispensing pharmacies. It discusses approved medicines and possible off-label prescribing in general without identifying what it actually offers. Consequently, this review cannot classify its treatment as a particular branded product, compounded preparation or specific prescribing use. The exact medication needs to be established during the clinical discussion, not inferred from the GLP-1 label.
Once a product is proposed, ask for its full name, formulation, route, presentation and pharmacy. Also establish whether Allure sends the prescription to an outside pharmacy, arranges dispensing through a designated channel or allows another pharmacy. The documentation does not answer those questions or specify whether medication is collected or shipped. Our pharmacy-handoff guide explains why prescribing and dispensing are separate responsibilities even when a program markets them together.
Regulatory context depends on that missing product identity. FDA approval applies to a specific drug, not to a clinic. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; that fact alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nothing in the consulted Allure material establishes that it supplies compounded medication.
Delivery and ongoing support need named responsibilities
The public documentation does not describe home delivery, collection, shipping fees, dispatch schedules, arrival estimates or replacement arrangements. It also does not say who manages refrigeration concerns. Those omissions do not demonstrate a delivery problem; they mean delivery cannot be evaluated from these pages. If medication will be shipped, establish who supplies tracking, who handles delays and which organization you should contact when a package or its contents do not match expectations.
For injectable GLP-1 medication that arrives warm or with insufficient refrigeration, FDA explicitly advises not using the product and contacting the provider or dispensing pharmacy. Allure’s public pages do not provide a program-specific procedure for that situation. Before a shipment is arranged, ask for the relevant contact and instructions. A general office number may be an entry point, but the documentation does not establish that it provides immediate clinical or pharmacy support.
For continuing care, Allure promises monitoring, ongoing medical-team support and plan adjustments when clinically appropriate. Its program description addresses progress, side effects and response, but does not specify appointment frequency, staff response times or after-hours coverage. The distinction between support being available and a defined clinical service is important. Use the questions in what ongoing GLP-1 support means to clarify scheduled reviews, between-visit concerns and responsibility for prescription renewals.
Keep the aesthetic membership separate from treatment costs
The most visible dollar amount in the reviewed material is not a GLP-1 price. Allure advertises an aesthetic membership starting at $179 per month, with benefits described as free Botox, member pricing, priority booking and complimentary treatments. That offer does not establish a medication charge, a weight-management membership or a combined clinical package. It should not be used to estimate what a patient will pay for GLP-1 care.
Allure’s general website advertises a free, no-pressure consultation with no commitment required and says personalized treatment plans outline treatments, timelines and pricing. The GLP-1 page does not expressly confirm that its consultation is free. Nor does it publish an itemized GLP-1 charge covering medication, testing, injection supplies and later consultations. Ask for a written breakdown distinguishing the first payment from subsequent charges and identifying the period each payment covers.
General billing FAQs discuss patient responsibility based on insurer-approved amounts, but they do not confirm GLP-1 coverage, accepted plans or prior-authorization assistance. The reviewed pages also do not document GLP-1 minimum commitments, automatic renewals, cancellation deadlines or refund rules. The page titled Terms & Conditions is principally about text messaging. Before paying, obtain the treatment-specific financial agreement rather than assuming the general consultation language or SMS terms settle those obligations.
Contact routes are published; clinical messaging is less defined
Allure publishes the same number for telephone and text contact: 1-800-577-2570. It also lists info@alluremedical.com. These are practical routes for asking which office provides GLP-1 care and requesting appointment or financial information. They do not establish a dedicated clinical messaging service, a patient portal or guaranteed response times. Confirm where treatment questions belong and whether messages are reviewed by clinical staff rather than assuming every contact route has the same function.
The SMS terms describe appointment reminders, treatment confirmations, post-care instructions and aesthetic promotional offers for patients who opt in. Message frequency depends on appointment frequency, and message and data charges may apply. Those terms should not be read as a promise of continuous clinical access. The reviewed documentation also does not confirm Spanish-language care, interpretation services or accessibility accommodations, so anyone needing those arrangements should establish them before scheduling.
Privacy deserves a separate question. Allure’s policy describes collecting medical conditions, prescriptions, medical photos, laboratory results and billing-related information. It identifies analytics and advertising technologies, including Google Analytics, Mixpanel and advertising-network cookies or pixels. It permits certain sharing with healthcare providers, pharmacies and marketing partners, yet also says personal or mobile data is not shared for third-party marketing. The scope of those statements is difficult to reconcile from the policy alone; ask which protections apply to medical intake versus ordinary website activity.
Judge the proposed plan by its specifics, not the program label
Allure documents a recognizable clinical structure: an initial health review, an individualized recommendation for candidates, education and continuing monitoring. What the public record cannot establish is how consistently or promptly those services are delivered. There was no treatment purchase, observed consultation or evaluation of individual patient outcomes for this review. Provider descriptions of a structured or safer approach remain the provider’s claims, not independent findings about the quality or safety of its care.
NIDDK explains that medication selection involves benefits, side effects, other medicines, health conditions, family history and costs. Follow-up concerns tolerability and response, not simply renewed payments. Treatment duration depends on response and side effects, and obesity may require long-term care. That context makes Allure’s unspecified follow-up schedule and payment structure consequential: a prospective patient needs to understand how clinical decisions and financial obligations interact over time.
Before committing, request a plan that names the treating clinician, exact medication, dispensing pharmacy, access method, monitoring schedule and total itemized charges. Ask who takes responsibility when a prescription, delivery or follow-up problem crosses organizational boundaries. Allure’s published information provides a reasonable starting point for that conversation, but not a complete operational answer. A clear response to those questions would make the difference between understanding an advertised program and understanding the care you are actually considering.
Questions & answers
Does Allure Medical actually advertise GLP-1 treatment?
Yes. Its dedicated page advertises medical weight loss with GLP-1 injections and describes prescription medication, screening, monitoring, lifestyle guidance and ongoing support. That confirms an advertised program, not a guaranteed prescription. The consulted pages do not identify the exact medicines or dispensing pharmacies, so those details require confirmation during the care process.
Is Allure’s GLP-1 program $179 per month?
That is not a documented GLP-1 price. The offer starting at $179 per month is an aesthetic membership advertising Botox and other member benefits. Allure does not publish a GLP-1 price in the consulted material. Request separate figures for the evaluation, medication, laboratory work, supplies and follow-up, plus the billing interval and any ongoing commitment.
Can I receive Allure GLP-1 care entirely through telehealth?
The reviewed documentation does not establish that. Allure advertises virtual visits and same-day appointments generally, and its GLP-1 page lists locations in Michigan, North Carolina and South Carolina. Neither statement confirms fully remote GLP-1 care or statewide access. Ask whether your initial assessment, testing and later reviews can be completed remotely from your location.
What should I bring to an Allure consultation?
Allure asks for medication and supplement lists, relevant medical history and information about previous weight-loss programs, medicines or surgeries. It also expects discussion of nutrition, activity, sleep and stress. Ask ahead whether it needs existing laboratory results or records from another clinician. The public pages do not specify a universal testing requirement or explain whether testing is included in the price.
Does Allure ship the medication or use a particular pharmacy?
The consulted pages do not identify a dispensing pharmacy or document shipping and collection arrangements. Before accepting a plan, ask who dispenses the product, whether a specific pharmacy channel is required and who handles delivery problems. If an injectable GLP-1 arrives warm or insufficiently refrigerated, FDA advises not using it and contacting the provider or dispensing pharmacy.
How do I contact Allure about follow-up or program terms?
Allure lists phone and text contact at 1-800-577-2570 and email at info@alluremedical.com. Use those channels to request the GLP-1 team’s clinical contact process and written financial terms. Published contact details do not establish urgent response coverage. Likewise, the general SMS terms do not resolve GLP-1 cancellation, renewal or refund arrangements.
Our assessment
Allure Medical documents more than a medication inquiry form: it describes screening, individualized planning, education and clinical follow-up within a broader physician-led practice. Its preparation guidance is useful, and its published contact channels provide a way to investigate the program. The principal limitation is an incomplete public account of the middle and financial portions of care—specific product, dispensing pharmacy, delivery arrangements, monitoring cadence and GLP-1 charges. The aesthetic membership price does not fill that gap. A sensible next step is to request a written, location-specific care and cost plan before making a payment. The program can be evaluated more meaningfully once those responsibilities and terms are explicit; the consulted documentation alone does not support a stronger judgment about delivery quality or treatment outcomes.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Allure Medical — raleigh nc ↗
- Allure Medical — privacy policy ↗
- Allure Medical — raleigh nc/inside/weight management ↗
- Allure Medical — about us ↗
- Allure Medical — raleigh nc/outside/treatments/glp 1 agonist ↗
- Allure Medical — terms conditions ↗